Google
Trusted Resources: News & Events
Latest announcements and gatherings
Study Confirms Safe Use of Opioids for Pain Control in Sickle Cell Disease
The most common cause of hospital admission among patients with sickle cell disease (SCD) are excruciating pain crises, for which opioid medications are a mainstay of treatment. There have been questions about whether the US opioid epidemic, which has resulted in large increases in opioid-related overdoses and deaths over the past 2 decades, may have affected the death rate among patients with SCD who were treated with opioids in the hospital to relieve pain crises.
According to a study results presented at the 60th American Society of Hematology Annual Meeting & Exposition in San Diego, California, on December 2, 2018, the use of opioid medications for pain control in SCD is relatively safe, and there has been no associated increase in hospital SCD mortality.
+myBinderRelated Content
-
Opioid management strategy decreases admissions in high-utilizing adults with sickle cell diseaseBackground: A subset of adults with sic...
-
A multiple drug approach to preventing sickle cell crisisSickle cell disease is characterized by ...
-
The effects of pain-related anxiety on hypnosis treatment responses in adults with and without sickle cell diseasePain is the most common symptom in sickl...
-
New treatment plan leads to better pain control for acute sickle cell crisisThere’s new hope for the 70,000 to 80,...
-
How sickled red blood cells stick to blood vesselsOne of the most common complications o...
-
Living With Sickle Cell Disease Is a Constant Battle With Pain, According to one Woman Who Has It“You don’t look sick.” That’s ...
-
APS Scientific Meeting 2019The American Pain Society will hold its ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.